Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 322
6
Diseases
6
Unique genes
0.309
Avg. similarity score
Hereditary hyperekplexia
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hereditary hyperekplexia
Hyperekplexia
Hyperexplexia hereditary
Retinitis pigmentosa, juvenile cataract, short stature, intellectual disability syndrome
sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
hyperekplexia 3
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hereditary hyperekplexia | 5 | 5 | 5 |
| Hyperekplexia | 5 | 5 | 5 |
| Hyperexplexia hereditary | 5 | 5 | 4 |
| Retinitis pigmentosa, juvenile cataract, short stature, intellectual disability syndrome | 4 | 4 | 2 |
| sulfite oxidase deficiency due to molybdenum cofactor deficiency type C | 4 | 4 | 1 |
| hyperekplexia 3 | 3 | 3 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GPHN | 5 / 6 | Hereditary hyperekplexia, Hyperekplexia, Hyperexplexia hereditary, Retinitis pigmentosa, juvenile cataract, short stature, intellectual disability syndrome and 1 more |
| SLC6A5 | 4 / 6 | Hereditary hyperekplexia, Hyperekplexia, hyperekplexia 3, Hyperexplexia hereditary |
| GLRA1 | 3 / 6 | Hereditary hyperekplexia, Hyperekplexia, Hyperexplexia hereditary |
| GLRB | 3 / 6 | Hereditary hyperekplexia, Hyperekplexia, Hyperexplexia hereditary |
| ATAD1 | 2 / 6 | Hereditary hyperekplexia, Hyperekplexia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Neurotransmitter receptors and postsynaptic signal transmission | Reactome | 2 / 9 | 445× | 7.48e-6 | 2.63e-4 ✓ sig. |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | Reactome | 1 / 1 | 2,002× | 5.00e-4 | 7.96e-3 ✓ sig. |
| Biosynthesis of cofactors | KEGG | 2 / 154 | 26.0× | 2.37e-3 | 2.58e-2 ✓ sig. |
| Molybdenum cofactor biosynthesis | Reactome | 1 / 6 | 334× | 2.99e-3 | 3.07e-2 ✓ sig. |
| Na+/Cl- dependent neurotransmitter transporters | Reactome | 1 / 19 | 105× | 9.46e-3 | 6.63e-2 |
| The canonical retinoid cycle in rods (twilight vision) | Reactome | 1 / 20 | 100× | 9.95e-3 | 6.82e-2 |
| Class I peroxisomal membrane protein import | Reactome | 1 / 20 | 100× | 9.95e-3 | 6.82e-2 |
| RA biosynthesis pathway | Reactome | 1 / 22 | 91.0× | 1.09e-2 | 7.25e-2 |
| Neuroactive ligand-receptor interaction | KEGG | 2 / 370 | 10.8× | 1.31e-2 | 8.01e-2 |
| Folate biosynthesis | KEGG | 1 / 28 | 71.5× | 1.39e-2 | 8.31e-2 |
| Retinoid metabolism and transport | Reactome | 1 / 41 | 48.8× | 2.03e-2 | 1.04e-1 |
| Retinol metabolism | KEGG | 1 / 68 | 29.4× | 3.35e-2 | 1.37e-1 |
| Synaptic vesicle cycle | KEGG | 1 / 79 | 25.3× | 3.88e-2 | 1.49e-1 |
| GABAergic synapse | KEGG | 1 / 89 | 22.5× | 4.37e-2 | 1.59e-1 |
| Metabolic pathways | KEGG | 2 / 1,563 | 2.6× | 1.78e-1 | 3.41e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| synaptic transmission, glycinergic | GO:0060012 | 3 / 3 | 3,115× | 1.84e-11 | 6.34e-9 ✓ sig. |
| gamma-aminobutyric acid receptor clustering | GO:0097112 | 2 / 6 | 1,038× | 1.29e-6 | 1.01e-4 ✓ sig. |
| righting reflex | GO:0060013 | 2 / 9 | 692× | 3.09e-6 | 2.04e-4 ✓ sig. |
| startle response | GO:0001964 | 2 / 18 | 346× | 1.31e-5 | 6.45e-4 ✓ sig. |
| acrosome reaction | GO:0007340 | 2 / 18 | 346× | 1.31e-5 | 6.45e-4 ✓ sig. |
| visual perception | GO:0007601 | 3 / 215 | 43.5× | 2.93e-5 | 1.20e-3 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 3 / 236 | 39.6× | 3.87e-5 | 1.48e-3 ✓ sig. |
| adult walking behavior | GO:0007628 | 2 / 34 | 183× | 4.80e-5 | 1.74e-3 ✓ sig. |
| neuromuscular process | GO:0050905 | 2 / 42 | 148× | 7.36e-5 | 2.41e-3 ✓ sig. |
| excitatory postsynaptic potential | GO:0060079 | 2 / 69 | 90.3× | 2.00e-4 | 5.04e-3 ✓ sig. |
| chloride transport | GO:0006821 | 2 / 81 | 76.9× | 2.75e-4 | 6.32e-3 ✓ sig. |
| regulation of membrane potential | GO:0042391 | 2 / 85 | 73.3× | 3.03e-4 | 6.77e-3 ✓ sig. |
| glycine receptor clustering | GO:0072579 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| extraction of mislocalized protein from mitochondrial outer membrane | GO:0140570 | 1 / 1 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| neuropeptide signaling pathway | GO:0007218 | 2 / 111 | 56.1× | 5.16e-4 | 9.77e-3 ✓ sig. |